Trials / Unknown
UnknownNCT01079455
Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip
Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip Controlled With Intra-articular Injections With Bupivacaine
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 489 (estimated)
- Sponsor
- University Hospital Pellenberg · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Abstract Background: The effect of intra-articular treatment of hip osteoarthritis with hyaluronic acid in the hip joint is not based on large randomized controlled trials. Hyaluronic acid is a well established treatment for osteoarthritis of the knee. Methods: Randomized controlled trial with three-armed parallel-group design. The patients meeting the inclusion criteria will be randomized into one of the following groups: infiltration of the hip joint with hyaluronic acid, with corticosteroids or with bupivacaine 0,125%. Pain VAS, Harris Hip Score and HOOS were scored during follow-up. The patients will be asked to determine their situation as worse, stabile or better then at the time of enrollment. There will be asked if they use painkillers and if they have complications/adverse events. These outcome measure instruments will be used at the time of enrollment in the study prior to any injection, and then again at six weeks, 3 and 6 months after the initial injection. The six-month follow-up period begins for all patients on the date the first injection will be administered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corticosterone | Hyaluronic acid 40 mg / 2 ml Corticosteroids 80 mg / 2 ml Bupivacaine 0.125% / 2 ml |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-07-01
- Completion
- 2013-12-01
- First posted
- 2010-03-03
- Last updated
- 2010-03-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01079455. Inclusion in this directory is not an endorsement.